The TNF-a blockers have made Harvard Medical School's list of top health stories of 2007. Three TNF-a blockers currently on the market are approved for treating ankylosing spondylitis: Enbrel, Remicade and Humira.

An article on Dentalplans.com states that, "Sales of the TNF-alpha blockers have more than tripled since 2002, according to IMS Health."

For more information on the TNF-a Inhibitors, please visit the medications page: click here and our ongoing report on this class of mediations: click here.

One of the problems with this class of medications is their high cost. Please note that there are several programs that can assist in the payments for these medications: click here.

To read Harvard Medical School's list of top health stories of 2007, please click here.

STAY INFORMED! Stay up-to-date on all the latest news and information regarding AS and related diseases with our news magazine, Spondylitis Plus. Your subscription comes free with SAA membership, so click here to join today!